TRCT
NMTR

Tower Research Capital (TRC)’s 9 Meters Biopharma NMTR Stock Holding History

Tower Research Capital (TRC)’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,709
Closed -$4.51K – 6467
2023
Q2 		$4.51K Buy
6,709
+1,701
+34% +$1.5K ﹤0.01% 4942
2023
Q1 		$7K Buy
5,008
+4,295
+602% +$8.1K ﹤0.01% 4804
2022
Q4 		$1K Sell
713
-798
-53% -$1.82K ﹤0.01% 5771
2022
Q3 		$6K Buy
+1,511
New +$7.49K ﹤0.01% 5097
2022
Q2 		– Sell
-766
Closed -$9K – 6798
2022
Q1 		$9K Buy
766
+158
+26% +$2.16K ﹤0.01% 4525
2021
Q4 		$12K Sell
608
-72
-11% -$1.61K ﹤0.01% 4357
2021
Q3 		$17K Sell
680
-441
-39% -$10.4K ﹤0.01% 3900
2021
Q2 		$25K Buy
1,121
+788
+237% +$19.3K ﹤0.01% 3703
2021
Q1 		$8K Buy
+333
New +$10.2K ﹤0.01% 4495
2020
Q3 		– Sell
-9,431
Closed -$108K – 5201
2020
Q2 		$108K Buy
+9,431
New +$106K ﹤0.01% 2390
2019
Q3 		– Sell
-130
Closed -$3K – 4653
2019
Q2 		$3K Buy
+130
New +$3.9K ﹤0.01% 3189
2019
Q1 		– Sell
-220
Closed -$10K – 4459
2018
Q4 		$10K Buy
+220
New +$16.3K ﹤0.01% 2488
2017
Q2 		– Sell
-3
Closed -$1K – 3635
2017
Q1 		$1K Buy
3
+1
+50% +$300 ﹤0.01% 2883
2016
Q4 		$1K Sell
2
-2
-50% -$580 ﹤0.01% 3686
2016
Q3 		$1K Buy
+4
New +$2.21K ﹤0.01% 3415

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Tower Research Capital (TRC)'s NMTR Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 6,709 shares — an estimated $4.51K sold.

Tower Research Capital (TRC) first reported a position in NMTR in Q3 2016 and held it in 15 quarters. The position peaked at $108K in Q2 2020. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6,709 9 Meters Biopharma shares in Q3 2023, an estimated $4.51K.
  • Tower Research Capital (TRC) first reported a position in 9 Meters Biopharma in Q3 2016 and held it in 15 quarters.
  • Tower Research Capital (TRC)'s 9 Meters Biopharma position peaked at $108K in Q2 2020.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.